A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE SAFETY AND EFFICACY OF PF-04965842 IN SUBJECTS WITH MODERATE TO SEVERE PSORIASIS.
Clinical Trial Grant
Administered By
Dermatology
Awarded By
Pfizer, Inc.
Start Date
March 23, 2015
End Date
March 30, 2016
Administered By
Dermatology
Awarded By
Pfizer, Inc.
Start Date
March 23, 2015
End Date
March 30, 2016